What is the BODE Index used for?

It is a prognostic tool for COPD that combines several measures instead of relying on FEV₁ alone.

How often should BODE be recalculated?

It is often reviewed periodically and after major clinical changes such as exacerbations or rehabilitation.

Is a low BMI really a risk factor in COPD?

Yes. In COPD, a low BMI can reflect poor nutritional status or cachexia and is associated with worse outcomes.

What BODE score qualifies for lung transplant evaluation?

Referral thresholds vary by guideline and clinical context, so local transplant criteria should be used.

Does the BODE Index account for exacerbation frequency?

No. Other tools add exacerbation history, but the BODE Index does not.

Can the BODE Index improve with treatment?

Yes. Improvements in exercise capacity, dyspnea, nutrition, and overall COPD control can improve the score.

BODE Index Calculator

Calculate the BODE Index for COPD prognosis. Combines BMI, airflow obstruction (FEV₁), dyspnea (mMRC), and exercise capacity (6MWD) for mortality prediction.

⚠️ Medical Disclaimer: This calculator is for educational purposes. BODE Index assessment should be performed by a pulmonologist or COPD specialist. Do not use for self-diagnosis.

FEV₁ (% predicted)

6-Minute Walk Distance

meters

Dyspnea (mMRC Scale)

Weight

Height

BODE Index3 / 10

Mortality Risk

Moderate Risk

4-Year Mortality: ≈32%

BMI (B)

0/1

Obstruction (O)

1/3

Dyspnea (D)

1/3

Exercise (E)

1/3

BODE Index

3 / 10

Q2 (3-4) — Moderate Risk

4-Year Mortality

≈32%

Estimated 4-year all-cause mortality

2-Year Mortality

≈15%

Estimated 2-year all-cause mortality

BMI

24.2

BMI > 21 — no additional points

FEV₁ Points

1 / 3

FEV₁ 50% predicted

6MWD Points

1 / 3

Distance: 300 meters

Component	0 pts	1 pt	2 pts	3 pts
FEV₁ (%)	≥65	50-64	36-49	≤35
6MWD (m)	≥350	250-349	150-249	≤149
Dyspnea	mMRC 0-1	mMRC 2	mMRC 3	mMRC 4
BMI	>21	≤21	—	—

Quartile	Score	2-Year Mortality	4-Year Mortality
Q1	0-2	~6%	~15%
Q2	3-4	~15%	~32%
Q3	5-6	~25%	~40%
Q4	7-10	~50%	~80%

Planning notes, formulas, and examples

About the BODE Index Calculator

The BODE Index Calculator estimates prognosis in chronic obstructive pulmonary disease (COPD) by combining body mass index, airflow obstruction measured by FEV₁, dyspnea measured by the mMRC scale, and exercise capacity measured by 6-minute walk distance. It is a multidimensional score used in stable COPD.

Scores range from 0 to 10, with higher scores indicating worse prognosis. The index groups patients into quartiles with different survival estimates.

When This Page Helps

FEV₁ alone captures only one part of COPD severity. The BODE Index adds information about nutrition, dyspnea, and exercise tolerance.

It can support prognostic discussion, rehabilitation planning, and follow-up assessment alongside other COPD measures.

How to Use the Inputs

Obtain spirometry results and enter FEV₁ as percent predicted.
Conduct a 6-minute walk test in a suitable corridor and record the distance in meters.
Assess dyspnea using the modified MRC (mMRC) dyspnea scale.
Measure the patient weight and height to calculate BMI.
The calculator automatically computes the BODE Index and mortality quartile.
Review the component breakdown to identify areas for targeted intervention.
Repeat the assessment periodically to track disease progression.

Formula used

BODE Index = B + O + D + E

B (BMI): ≤21 → 1 pt; >21 → 0 pts
O (FEV₁% pred): ≥65 → 0; 50-64 → 1; 36-49 → 2; ≤35 → 3
D (mMRC): 0-1 → 0; 2 → 1; 3 → 2; 4 → 3
E (6MWD): ≥350m → 0; 250-349 → 1; 150-249 → 2; ≤149 → 3

Total Range: 0-10

Example Calculation

Result: BODE 3 — Moderate Risk (Quartile 2)

FEV₁ 50% (1 pt) + 6MWD 300 m (1 pt) + mMRC 2 (1 pt) + BMI 24.2 (0 pts) = BODE 3. This places the patient in Quartile 2.

Tips & Best Practices

The 6-minute walk test requires a standardized 30m corridor with encouragement given at set intervals.
Use post-bronchodilator FEV₁ for BODE calculation.
Pulmonary rehabilitation can improve BODE by 1-2 points, primarily through exercise capacity and dyspnea.
BMI ≤21 triggers only 1 point — cachexia is binary in BODE, not graded.
BODE changes of ≥1 point after interventions should be considered clinically significant.
Combine BODE with GOLD staging and exacerbation history for comprehensive COPD management.

Original BODE Study

Celli et al. (NEJM 2004) validated the BODE Index in 876 COPD patients, demonstrating superior mortality prediction compared to FEV₁ alone. The index was applied to two independent cohorts from the US and Spain, showing consistent predictive power. Each 1-point increase in BODE was associated with a 34% increase in all-cause mortality and a 62% increase in respiratory mortality.

Clinical Applications Beyond Prognosis

The BODE Index has applications in lung transplant evaluation (ISHLT guidelines), lung volume reduction surgery assessment, pulmonary rehabilitation outcomes, and clinical trial stratification. Changes in BODE after interventions serve as a composite endpoint that captures multiple dimensions of treatment effect.

Comparison with Other COPD Scores

Alternatives include the ADO Index (Age, Dyspnea, Obstruction), DOSE index (Dyspnea, Obstruction, Smoking, Exacerbations), and the GOLD combined assessment (symptoms + exacerbations). Each has different data requirements and strengths. BODE remains the best-validated tool for prognosis in stable COPD.

Sources & Methodology

Last updated: March 26, 2026

Methodology

This calculator applies the original BODE framework by assigning points for body mass index, airflow obstruction by post-bronchodilator FEV1 percent predicted, dyspnea by the mMRC scale, and 6-minute walk distance. The four components are summed into the usual 0-10 total and then grouped into the BODE quartiles commonly used in COPD prognosis discussions.

The output is a stable-COPD prognostic aid rather than a stand-alone treatment plan. Exacerbation history, smoking status, oxygen need, imaging findings, and transplant or rehabilitation decisions still require a broader pulmonary assessment beyond the BODE total alone.

Sources

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease (PubMed / New England Journal of Medicine)
Pulmonary rehabilitation and the BODE index in COPD (PubMed / European Respiratory Journal) — Shows how BODE changes can reflect clinical improvement after rehabilitation.

Frequently Asked Questions

It is a prognostic tool for COPD that combines several measures instead of relying on FEV₁ alone.